Samaras et al. [27] showed that the expression of p38 was correlated with a high Fuhrman’s index in patients with renal cell carcinoma, indicating the usage of p38 suppression as a new therapeutic method in cancerogenesis. This evidence concerns the gene MAPK1 and renal cell carcinoma.